Skip to main content

par C346 (Memantine Hydrochloride Extended-Release 7 mg)

Pill with imprint par C346 is Yellow, Capsule-shape and has been identified as Memantine Hydrochloride Extended-Release 7 mg. It is supplied by Par Pharmaceutical, Inc.

Memantine is used in the treatment of alzheimer's disease and belongs to the drug class miscellaneous central nervous system agents. There is no proven risk in humans during pregnancy. Memantine 7 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for par C346

Memantine Hydrochloride Extended-Release

par C346
7 mg
14.00 mm
Prescription only
Drug Class
Miscellaneous central nervous system agents
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Par Pharmaceutical, Inc.
National Drug Code (NDC)
Inactive Ingredients
sucrose, corn starch, hydroxypropyl cellulose (type e), magnesium silicate, ethylcellulose, triethyl citrate, polyethylene glycol 3350, titanium dioxide, gelatin, shellac, ferrosoferric oxide, FD&C Blue No. 2, FD&C Red No. 40, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Yellow No. 6

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.